From October 1, 2023 to December 31, 2023, the company has repurchased 1,100,000 shares, representing 1.3% for $227.54 million. With this, the company has completed the repurchase of 12,359,458 shares, representing 13.58% for $2,946.8 million under the buyback announced on December 9, 2021.
Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
207.7 USD | +0.74% | +3.15% | -8.63% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.63% | 17.51B | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.65% | 29.06B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.23% | 12.42B | |
+6.43% | 12.77B | |
+31.27% | 12.06B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Tranche Update on Laboratory Corporation of America Holdings (NYSE: LH)'s Equity Buyback Plan announced on December 9, 2021.